<DOC>
	<DOCNO>NCT00002101</DOCNO>
	<brief_summary>To compare efficacy clarithromycin/ethambutol placebo rifabutin two different dos reduce colony-forming unit ( CFUs ) 2 logarithms patient Mycobacterium avium Complex bacteremia maintain response 16 week post-randomization . To assess survival comparative tolerability among three treatment regimen .</brief_summary>
	<brief_title>A Three-Arm Comparative Trial Treatment MAC Bacteremia AIDS : A Clarithromycin/Ethambutol Regimen Containing Rifabutin ( 450 Mg ) Rifabutin ( 300 Mg ) Placebo</brief_title>
	<detailed_description>Patients randomize receive clarithromycin ethambutol plus either placebo rifabutin one two dos . Treatment continue indefinitely . AS PER AMENDMENT 04/19/94 : Doses rifabutin lower .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Ethambutol</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Isoniazid TB prophylaxis ONLY . Patients must : HIV infection . MAC infection . Life expectancy least 16 week . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Perceived unreliability unavailability frequent monitoring . Concurrent Medication : Excluded : Antimycobacterial drug study drug . Carbamazepine . Terfenadine . Theophylline . Patients follow prior condition exclude : History hypersensitivity rifabutin , rifampin , erythromycin , clarithromycin , azithromycin , ethambutol . Prior Medication : Excluded within 7 day prior study entry : Rifabutin . Rifampin . Ethionamide . Cycloserine . Clofazimine . Ethambutol . Amikacin . Ciprofloxacin . Ofloxacin . Sparfloxacin . Azithromycin . Clarithromycin . Pyrazinamide . Excluded within 14 day prior study entry : Carbamazepine . Terfenadine . Theophylline .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Rifabutin</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Ethambutol</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Clarithromycin</keyword>
</DOC>